ArriVent BioPharma, Inc.
Historical 13F Holders
Symbol
AVBP
CUSIP
04272N102
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q2
100
33.6 M
$732 M
$0
2025 Q1
84
29.1 M
$539 M
$0
2024 Q4
81
28.5 M
$757 M
$0
2024 Q3
70
25.9 M
$612 M
$0
2024 Q2
57
21.7 M
$405 M
$0
2024 Q1
57
21.9 M
$390 M
$0